Financing Guide · Dermatology Practice

How to Finance a Dermatology Practice Acquisition

From SBA 7(a) loans to seller notes, understand the capital stack options available to physician buyers and investors acquiring dermatology practices in the $1M–$5M revenue range.

Dermatology practices are among the most financeable medical specialties due to predictable recurring revenue, strong EBITDA margins, and dual income streams from both insurance-reimbursed medical services and high-margin cash-pay cosmetics. Lenders favor practices with diversified payer mixes, 2+ licensed providers, and documented patient volume. Most acquisitions in the $2M–$8M purchase price range are structured using SBA 7(a) loans as the primary debt instrument, supplemented by seller notes and occasionally equity from PE-backed platforms or physician investors.

Financing Options for Dermatology Practice Acquisitions

SBA 7(a) Loan

$500,000–$5,000,000Prime + 2.25%–2.75% (currently ~10.5%–11%)

The most common financing tool for independent buyers acquiring dermatology practices. SBA 7(a) loans cover up to 90% of the purchase price, making them ideal for physician entrepreneurs with limited upfront capital.

Pros

  • Low down payment requirement (10%) preserves working capital for post-close operations and integration
  • Long 10-year repayment terms lower monthly debt service relative to conventional loans
  • Widely accepted by healthcare lenders familiar with MSO deal structures and corporate practice of medicine rules

Cons

  • ×Personal guarantee required, creating personal liability exposure for physician buyers
  • ×Lender underwriting can be lengthy, adding 60–90 days to deal timelines
  • ×SBA may restrict certain deal structures, including equity rollovers and earnouts, complicating PE-style transactions

Seller Financing (Seller Note)

$200,000–$1,000,0006%–8% fixed, negotiated between buyer and seller

The selling physician defers a portion of the purchase price, typically 10–20%, structured as a promissory note. Often paired with SBA financing to bridge valuation gaps or reduce buyer cash requirements at close.

Pros

  • Signals seller confidence in practice performance and reduces buyer equity requirement at closing
  • Flexible repayment terms can be subordinated to SBA debt, satisfying lender requirements
  • Aligns seller incentives with a smooth transition, supporting physician retention and patient continuity

Cons

  • ×Seller assumes credit risk if the buyer defaults post-close, which may deter risk-averse physician founders
  • ×Subordination to SBA debt limits seller's recovery options in a default scenario
  • ×Short note terms of 3–5 years may create cash flow pressure alongside primary SBA debt service

Private Equity or Equity Co-Investment

$1,000,000–$5,000,000+Equity return targets of 20%–30% IRR; no fixed interest rate

PE-backed dermatology roll-up platforms or physician investment groups contribute equity capital in exchange for ownership stakes, typically paired with institutional debt financing for larger platform acquisitions.

Pros

  • Access to significant capital enables larger acquisitions beyond SBA loan limits
  • PE platforms bring operational infrastructure, EMR integration, and billing expertise to accelerate EBITDA growth
  • Physician founders can retain minority equity, participating in upside through platform-level exit events

Cons

  • ×Significant equity dilution reduces physician owner's long-term economic ownership
  • ×PE buyers impose governance controls, reporting requirements, and performance-based earnout pressure
  • ×Not suitable for independent buyers; primarily relevant for institutional or roll-up acquisition scenarios

Sample Capital Stack

$4,500,000 (dermatology practice at 5x EBITDA on $900,000 EBITDA)

Purchase Price

~$42,000/month combined (SBA loan ~$38,000 + seller note ~$4,000 at 6% over 5 years)

Monthly Service

Approximately 1.45x DSCR at $900,000 EBITDA; above the 1.25x minimum threshold most SBA lenders require for healthcare practice loans

DSCR

SBA 7(a) Loan: $3,600,000 (80%) | Seller Note: $450,000 (10%) | Buyer Equity/Down Payment: $450,000 (10%)

Lender Tips for Dermatology Practice Acquisitions

  • 1Separate cosmetic cash-pay revenue from insurance-reimbursed medical revenue in your financials; lenders discount cosmetic income more heavily due to its discretionary nature.
  • 2Work with SBA lenders experienced in healthcare and MSO structures; not all lenders understand corporate practice of medicine compliance requirements in dermatology acquisitions.
  • 3Secure a physician employment agreement or transition consulting agreement from the seller before submitting to lenders; provider continuity directly impacts lender approval confidence.
  • 4Present 3 years of clean, reviewed financials with addbacks clearly documented; unexplained owner perks or inconsistent collections histories are the top reasons dermatology deals lose financing.

Frequently Asked Questions

Can I use an SBA loan to buy a dermatology practice structured as an MSO?

Yes. SBA 7(a) loans are compatible with MSO structures commonly used in dermatology to comply with corporate practice of medicine laws, provided the MSO and PC are properly structured and disclosed to the lender.

What EBITDA is required to qualify for SBA financing on a dermatology acquisition?

Most SBA lenders require minimum $300,000–$400,000 in adjusted EBITDA and a debt service coverage ratio of at least 1.25x after accounting for owner compensation and all debt obligations.

How does cosmetic revenue affect lender underwriting for a dermatology practice acquisition?

Lenders often apply a haircut to cosmetic revenue due to its discretionary nature. Practices with more than 50% cosmetic revenue may face tighter scrutiny or require larger down payments to offset perceived income volatility.

Is seller financing required when using an SBA loan to buy a dermatology practice?

Not always, but SBA lenders frequently require a seller note of 10–15% when the practice's goodwill is primarily physician-dependent, ensuring the seller has financial incentive to support a successful ownership transition.

More Dermatology Practice Guides

Ready to finance your Dermatology Practice acquisition?

DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.

Start finding deals — free

No credit card required